Safety of Empagliflozin in Patients with Type 2 Diabetes Mellitus in Saudi Arabia: A Post-Authorisation Safety Study

Journals Menu

Follow SCIRP

ISSN Print: 2158-284X
ISSN Online: 2158-2882
www.scirp.org/journal/ijcm
E-mail: ijcm@scirp.org

Citations

"Safety of Empagliflozin in Patients with Type 2 Diabetes Mellitus in Saudi Arabia: A Post-Authorisation Safety Study"
written by Saud Alsifri, Abdulrahman M. Almaghamsi, Ashraf S. Mahfouz, Walid Shehab-Eldin, Sameh Rakha,
published by International Journal of Clinical Medicine, Vol.14 No.3, 2023

has been cited by the following article(s):

[1]	Frequency of UTI in Diabetic Patients taking SGLT2 Inhibitors

Follow SCIRP

[1]	A Cross-Sectional Retrospective Study Assessing Potentially Inappropriate Medications for Elderly Diabetic Patients in a Tertiary Care Hospital in Saudi Arabia Risk Management and Healthcare Policy, 2024 DOI:10.2147/RMHP.S484334